In addition to GS active complexes of the expected Mr (390 kDa for decameric GS1 and 420 kDa for decameric GS2), additional slow migrating and fast migrating protein complexes were detected.
Moreover, the mRNA expression of the proteins responsible for the inhibition of cyclin-cdk active complexes of the G1 and S phases of HeLa and HepG2 cells exposed to the IC50 of MBS extracts were studied as well, namely tumor suppressor proteins p27, p21, and p53.
Recent studies have further revealed that the active complexes of both the prokaryotic and eukaryotic RNRs are dynamic.
The obtained results suggest that both of these QM/MM methods, and the stochastic boundary molecular dynamics approach applied in this work, can give reasonable results for modelling the catalytically active complex of this important enzyme.
In particular, transcription may disturb binding of proteins forming active complexes on the enhancers.
These results also suggest that the formation of a transcriptionally active complex on the DNA is important for the degradation of p63.
Regarding the former, diabetic diaphragm has reduced uptake and phosphorylation of glucose, phosphorylation of fructose-6-phosphate, glycolysis, oxidation of pyruvate and acetate, uptake of acetoacete, production of glycogen, the proportion of the active complex of pyruvate dehydrogenase, and activities of hexokinase, phosphorylase and phosphofructokinase [15] [22].
Diabetic diaphragm has reduced uptake and phosphorylation of glucose, phosphorylation of fructose-6-phosphate, glycoysis, oxidation of pyruvate and acetate, uptake of acetoacete, production of glycogen, the proportion of the active complex of pyruvate dehydrogenase, and activites of hexokinase, phosphorylase and phosphofructokinase [ 20- 27].
We previously reported that the active complex of pol V Mut is composed of pol V-RecA-ATP (Jiang et al., 2009).
Cyclin D1 binding to CDK4/6 forms the active complex of Cyclin D1-CDK4/6, which phosphorylates retinoblastoma protein (pRb) and subsequently releases E2F transcription factors, resulting in the activation of specific gene expression required for G1 to S phase progression [ 19].
Pulmonary surfactant (PS) is a surface active complex of lipids and proteins that prevents the alveolar structures from collapsing and reduces the work of breathing by lowering the surface tension at the alveolar air liquid interface (ALI).
